No Data
Compass Therapeutics to Host Webcast Highlighting Top-Line Clinical Data From the Ongoing Randomized Phase 2/3 Study Evaluating Tovecimig in Patients With Biliary Tract Cancer
Compass Minerals International, Inc. (CMP): A Bull Case Theory
Compass Point Downgrades Innovative Industrial Properties to Sell From Neutral, Cuts Price Target to $50 From $60
Institutional Owners May Consider Drastic Measures as Compass Diversified's (NYSE:CODI) Recent US$58m Drop Adds to Long-term Losses
Compass Minerals Announces Cost Cuts to Align With Business Needs
Express News | Cantor Fitzgerald Reiterates Overweight on Compass Pathwaysto Overweight
